American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Postmenopausal Osteoporosis
- 1 November 2010
- journal article
- Published by Elsevier BV in Endocrine Practice
- Vol. 16, 1-37
- https://doi.org/10.4158/ep.16.s3.1
Abstract
No abstract availableThis publication has 144 references indexed in Scilit:
- Exposure to Oral Bisphosphonates and Risk of Esophageal CancerJAMA, 2010
- Secular trends in hip fracture incidence and recurrenceOsteoporosis International, 2008
- Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trialBone, 2008
- Vitamin D Supplementation and Total MortalityA Meta-analysis of Randomized Controlled TrialsArchives of Internal Medicine, 2007
- Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 TrialJAMA, 2006
- Estimates of optimal vitamin D statusOsteoporosis International, 2005
- Effect of Vitamin D on FallsJAMA, 2004
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Epidemiology and outcomes of osteoporotic fracturesThe Lancet, 2002